Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern

Few data are available concerning the relationship between alveolar and blood cell populations during neutropenia. We wanted to compare the value of pulmonary endoscopic procedures with lavage in neutropenic (polymorphonuclear (PMN) count < or = 1,000.mm-3) and non-neutropenic settings. We therefore, retrospectively, reviewed the results of 118 investigations for pneumonia in patients with malignant haematological diseases. All had bronchoalveolar lavage (BAL), and some had additional studies with protected bacteriological samples. Each BAL specimen was studied after cytocentrifugation by cytological examination for opportunistic infections, haemorrhage, virus, legionellae, and bacteriological cultures. The diagnostic yield of all endoscopic procedures (BAL, telescoping plugged catheter and protected specimen brush) was 53% in neutropenic (Group 1) and 61% in non-neutropenic (Group 2) patients. The aetiological pattern of pneumonia was nearly the same in the two groups, except for more alveolar proteinosis in Group 1 and more cytomegalovirus (CMV) in Group 2. The absolute number of alveolar cells recovered through BAL (total number, macrophages, lymphocytes and PMNs) was significantly lower in neutropenic patients. We conclude that: 1) neutropenic patients with pneumonia require the same investigative approach as non-neutropenic patients; 2) profound neutropenia may be concomitant with a decreased cellularity of alveoli, which may reflect the consequences of marrow aplasia on the pulmonary cell population and/or direct effect of chemotherapy on the lung.

This article has been cited by other articles:

				E. Azoulay Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning Eur. Respir. J., January 1, 2009; 33(1): 6 - 8. [Full Text] [PDF]

				D. Stolz, A. Stulz, B. Muller, A. Gratwohl, and M. Tamm BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised Host Chest, August 1, 2007; 132(2): 504 - 514. [Abstract] [Full Text] [PDF]

				T. Peikert, S. Rana, and E. S. Edell Safety, Diagnostic Yield, and Therapeutic Implications of Flexible Bronchoscopy in Patients With Febrile Neutropenia and Pulmonary Infiltrates Mayo Clin. Proc., November 1, 2005; 80(11): 1414 - 1420. [Abstract] [PDF]

				D. Mokart, B. P. Guery, R. Bouabdallah, C. Martin, J.-L. Blache, C. Arnoulet, and J.-L. Mege Deactivation of Alveolar Macrophages in Septic Neutropenic ARDS Chest, August 1, 2003; 124(2): 644 - 652. [Abstract] [Full Text] [PDF]

				A T Jones, R M Du Bois, and A U Wells The pulmonary physician in critical care * Illustrative case 2: Interstitial lung disease Thorax, April 1, 2003; 58(4): 361 - 364. [Abstract] [Full Text] [PDF]

				F. Reichenberger, J.M. Habicht, A. Gratwohl, and M. Tamm Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Eur. Respir. J., January 1, 2001; 19(4): 743 - 755. [Abstract] [Full Text] [PDF]

				C. Mayaud and J. Cadranel A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host Thorax, June 1, 2000; 55(6): 511 - 517. [Full Text]

				J.-P. Latge Aspergillus fumigatus and Aspergillosis Clin. Microbiol. Rev., April 1, 1999; 12(2): 310 - 350. [Abstract] [Full Text] [PDF]

				C. P. Heussel, H.-U. Kauczor, G. E. Heussel, B. Fischer, M. Begrich, P. Mildenberger, and M. Thelen Pneumonia in Febrile Neutropenic Patients and in Bone Marrow and Blood Stem-Cell Transplant Recipients: Use of High-Resolution Computed Tomography J. Clin. Oncol., March 1, 1999; 17(3): 796 - 796. [Abstract] [Full Text] [PDF]

				F. REICHENBERGER, J. HABICHT, A. KAIM, P. DALQUEN, F. BERNET, R. SCHLAPFER, P. STULZ, A. P. PERRUCHOUD, A. TICHELLI, A. GRATWOHL, et al. Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 885 - 890. [Abstract] [Full Text] [PDF]